Roles in PharmNovo: Chief executive officer, Business advisor and Director of the board.
Born: 1960.
Education: Bachelor’s degree in International Business Administration from the University of Lund.
Other current appointments: None.
Work experience: 30 years experience from International business in various industries and has vast experience in developing and transforming mid-size businesses. In 2003–2007 Per was VP Marketing & Sales for Nybron Flooring, European market leader in parquet flooring, with HQ in Switzerland and during 2008-2017 he was CEO at Elfa International with HQ in Malmö, Sweden.
Holdings: 25 000 shares.
Roles in PharmNovo: Founder, President, Chief scientific advisor and Director of the board.
Born: 1949.
Education: PhD in Zoophysiology, Medical Physiology/Pharmacology, Histology.
Other current appointments: None.
Work experience: AstraZeneca 30 years. Visiting Fellow at University of Leicester 1.5 years, University of Iowa and University of Boston 1.5 year. Employed at AZ at the departments of Physiology, Bioscience, Pharmacology and Molecular Pharmacology. Principal scientist, group leader in IBS pain Molecular Pharmacology.
Holdings: 652 000 shares.
Roles in PharmNovo: Chief scientific officer and Director of the board.
Born: 1954.
Education: Professor. Pharmacy graduate with a PhD in Neuropharmacology and worked as an industrial pharmacologist before returning to academic research at the Universities of Texas and Leicester.
Other current appointments: None.
Work experience: 30 years of Academic and Industrial Research. Until August 2015, he was Professor of Pharmacology and former Head of Biomedical Sciences at the University of Nottingham Medical School.
Holdings: 250 000 shares.
Role in PharmNovo: Chief Financial Officer (CFO).
Born: 1957.
Education: Postgraduate diploma in International Business Leadership, University degree in Business Administration (BBA) from Lund University.
Other current appointments: Board member of three organisations.
Work experience: Tommy has over 40 years of industrial experience from mainly multinational corporations with different owner structures and in various industries (B2B, B2C), where the pharma industry is one. He has acted in a specialist function/role (accounting, controlling) as well as in a management/generalist capacity throughout his career, as employed and as interim manager. Examples of corporations as employed are Electrolux and Ericsson where he held senior finance positions. Tommy has also worked for Pharmacia Biotech (later acquired by Pfizer) in the 90’s as well as for other pharma companies, as employed and as interim. BRIO, Purac (water purification) and Precise Biometrics (fingerprint software) are examples of corporations where Tommy has acted as interim CFO. At Evry (IT) he held a position as interim CEO for one of the subsidiaries.
Holdings: None.
Role in PharmNovo: Project lead
Born: 1971
Education: DVM, PhD
Other current appointments: Project Director at KLIFO A/S, Independent Consultant, and Mentor at DeepTech Mentoring, Danish Technical University
Resumé:
Inge has a comprehensive understanding of scientific challenges and drug development processes allied with a strategic vision and a strong network, based on 20+ years of experience from both Academia and Industry. Her Industry roles span Clinical Development at Chr. Hansen A/S, Medical Affairs at Actelion, Global Project Lead, Head of Nonclinical Development and Head of R&D Operations at Savara ApS, Project Director at PokeAcell, and Senior Project Lead at KLIFO A/S.
Inges work experience is focused around; Leadership of multi-stakeholder, cross-functional drug development projects and project teams. Comprehensive cross-functional review of development projects with focus on gaps and timely solution to closing gaps. Taking hands-on roles in biotech/SMEs, mapping out nonclinical, clinical and regulatory parts of projects with focus on optimal timing of individual milestones and deliverables. Leading nonclinical activities including detailed analysis of nonclinical plans and timing of studies, outsourcing to CROs, and oversight of GLP studies.
Role in PharmNovo: Management assistant and communications lead.
Born: 1969.
Education: Postgraduate diploma in Strategic marketing (DipM Chartered institute of marketing), University certificate in polymer technology, Project management, pharmacology and digital marketing.
Other current appointments: None.
Work experience: Petra has over 20 years of experience from the pharma industry within product development, digital communications and marketing. She has worked for AstraZeneca and other pharma companies as well as for digital agencies during these years. When working for AstraZeneca as Global e-business manager she gained extensive experience in digital marketing and project management. During a few years she also held a position as project manager in an digital agency.
Holdings: None.
Roles in PharmNovo: Chemistry lead.
Born: 1959.
Education: B.Sc. in Chemistry and Ph.D. Preparative Organic Chemistry, Lund University. Associate Professor (docent) in Organic Pharmaceutical Chemistry, Uppsala University.
Other current appointments: None.
Work experience: Extensive experience from drug discovery and development and has held senior positions within a number of pharma and biotech companies, including AstraDraco, Acadia pharmaceuticals and KaroBio, where responsible for the chemical and pharmaceutical sciences and also intellectual property strategies. Associate professor of pharmaceutical chemistry and co-authored more than 100 scientific papers and patent applications.
Holdings: None.
Role in PharmNovo: Clinical lead.
Born: 1959.
Education: M.D. with specialization in Rehabilitation Medicine and Pain Medicine.
Ph.D. in physiology, Lund University.
Other current appointments: Senior Consultant Physician, part time, at different multidisciplinary pain and rehabilitation clinics in Stockholm (Sophiahemmet, ReAct Rehab, and PBM).
Work experience: Jarkko has over 30 years of experience in the pain field, including basic and clinical pain research, senior roles at several multidisciplinary pain clinics and 12 years of experience from the pharma industry as principal scientist and senior clinical research physician at AstraZeneca R&D Södertälje. working mainly with analgesic drug development.
Holdings: None.
Born: 1982.
Education: MSc. Pharmaceutical Sciences, BSc. Biotechnology.
Other current appointments: Senior Project Manager, KLIFO A/S, Denmark
Work experience: Having worked with both major global pharmaceutical companies and small biotech start-ups, Thomas has more than 15 years of experience working with the clinical trials,. Thomas’ work has been focused on all aspects of clinical trial managing including budget and timelines management, sponsor oversight, protocol and informed consent development, development study-specific documents, team training, data cleaning, and patient recruitment.
Holdings: None.
Role in PharmNovo: Clinical pharmacology lead, acting CMO.
Born: 1961.
Education: MD specialist in Clinical charmacology, PhD in Clinical biochemistry from Karolinska Institutet, University professional in pharmaceutical medicine from ECPM/University of Basel.
Other current appointments: Clinical trials unit/Department of Clinical pharmacology/Karolinska university hospital.
Work experience: +25 years in Pharmaceutical R&D, whereof 17 years within big and small pharmaceutical companies. Has held positions as medical adviser, principal scientist, project manager, and clinical pharmacology director. Areas of expertise span through preclinical R&D, translational sciences, and clinical development, including clinical evaluation of in-licensing opportunities. As trained pharmacokineticist, he has routinely developed and utilised modelling and simulation techniques to facilitate study design and data evaluation.
Holdings: None.
Role in PharmNovo: Consultant and toxicology advisor.
Company: Toxicology Knowledge Team Sweden.
Resumé: Kerstin has a PhD from Karolinska Institutet, Stockholm. Her research background is within the area of cell biology and DNA repair. She has 16 years of experience from toxicology at Safety Assessment, AstraZeneca, working as toxicology project leader and study director for in vivo toxicology studies, and within molecular toxicology. During the last 8 years she has been working at Toxicology Knowledge Team Sweden as a consultant and cofounder.
Role in PharmNovo: Regulatory affairs advisor.
Born: 1972.
Education: Cand Pharm.
Other current appointments: Work at Ozack Aps.
Work experience: Over 20 years of extensive regulatory experience from the pharma industry with 14 years at Novo Nordisk. Global experience across EU, US, China, Japan and rest of world from early as well as late-stage drug development projects including life-cycle management and with significant experience from interactions with regulatory authorities such as EMA, FDA, PMDA, CFDA and national EU agencies.
Holdings: None.
Role in PharmNovo: Clinical outsourcing lead.
Company: WIN Outsourcing Consult.
Resumé: Rikke is highly specialized and globally experienced within Pre-clinical and Clinical R&D, Business Development and Contract/Outsourcing Management and has worked in the CRO and Pharmaceutical industry within these fields for more than 25 years.
For almost two decades, she headed up the R&D Outsourcing & Contracts Management R&D function at Lundbeck where she was globally responsible for all R&D outsourcing matters covering contractual, operational and relationship related activities with all CROs/vendors as well as complex research collaborations agreements with academia. Rikke has significant experience in developing and executing a broad variety of outsourcing strategies and is a strong negotiator with a win-win approach to retaining positive relationships with all stakeholders.
Prior to her employment at Lundbeck, Rikke worked for five years within bio-analytical research and clinical development in hospital/academia settings. This was followed by four years of employment in a larger CRO (International Project Manager followed by setting up the CRO’s first South East Asia office working as Business Development Manager and Line Manager in Singapore).
Rikke has since 2013 been a Steering Committee member of the Pharmaceutical Contract Management Group (PCMG.org.uk) in Europe.
Role in PharmNovo: Regulatory affairs Lead.
Company: Ozack ApS.
Resumé: Ann Christine Korsgaard has for 25 years + headed up Global Regulatory Functions as Vice President in companies like Shionogi in UK, UCB in Belgium, and Genmab, Action Pharma, Actavis, and LEO Pharma in Denmark. Ann Christine has been the Global Regulatory Lead on numerous projects and led companies through strategic value creating interactions and meetings with the Health Authorities in especially Europe, US and Japan.
The many regulatory opportunities have taken her from small to bigger companies, from small molecules to biological/biotech, from EU to Global, from research organizations to generics, from early development to post-marketing activities, from HQ to affiliates, from authorities to industry, and from working in Denmark to Norway, Belgium, and UK.
